Furthermore, it has been reported that inhibition of Ezh2 by DZNep was able to reduce self-renewal and tumor-initiating features of glioblastoma multiforme CSCs in vivo through the transcriptional regulation of oncogene MYC (Suva et al., 2009). This evidence concerns the gene EZH2 and neoplasm.